Cibus (NASDAQ:CBUS) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Cibus (NASDAQ:CBUS) in a research report sent to investors on Monday morning,Benzinga reports. The firm currently has a $25.00 target price on the stock.

Several other analysts also recently weighed in on the company. Canaccord Genuity Group upgraded Cibus to a “strong-buy” rating in a research note on Friday, July 19th. Alliance Global Partners cut their price target on Cibus from $25.00 to $23.50 and set a “buy” rating on the stock in a research note on Tuesday, September 24th. Finally, Canaccord Genuity Group restated a “buy” rating and issued a $20.00 price target on shares of Cibus in a research note on Tuesday, October 22nd.

Cibus Trading Up 9.0 %

CBUS stock opened at $5.75 on Monday. Cibus has a fifty-two week low of $2.86 and a fifty-two week high of $23.18. The business’s 50 day moving average price is $4.08 and its two-hundred day moving average price is $8.75.

Institutional Trading of Cibus

Several institutional investors have recently added to or reduced their stakes in CBUS. Armistice Capital LLC bought a new stake in shares of Cibus in the 2nd quarter worth $5,083,000. Vanguard Group Inc. grew its holdings in shares of Cibus by 3.7% in the first quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock worth $16,215,000 after acquiring an additional 26,017 shares during the period. Rhumbline Advisers bought a new stake in shares of Cibus in the second quarter worth $221,000. FineMark National Bank & Trust grew its holdings in shares of Cibus by 24.3% in the second quarter. FineMark National Bank & Trust now owns 20,488 shares of the company’s stock worth $202,000 after acquiring an additional 4,000 shares during the period. Finally, Bank of New York Mellon Corp bought a new stake in shares of Cibus in the second quarter worth $529,000. 33.81% of the stock is currently owned by hedge funds and other institutional investors.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.